SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trading significantly lower following reports that merger discussions with Merck have collapsed due to disagreements over valuation. Despite the immediate sell-off, community sentiment remains split between investors bracing for further downside and those viewing the dip as a long-term entry point given the company's strong clinical data in RAS-targeted oncology.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is trending as the market prices in the potential for a gamma squeeze, fueled by its low float and persistent institutional buying pressure. Community discussion remains heavily focused on the stock's role as an asymmetric proxy for the HYPE token and broader decentralized finance infrastructure.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending due to its surge in institutional interest and significant trading volume, as it establishes itself as a leader in decentralized perpetual futures. The community is actively discussing its record-breaking fee buybacks, the anticipation of new crypto-related regulatory developments, and its role as a high-performance alternative to traditional assets.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors digest the company's recent ASCO plenary presentation, which showcased compelling overall survival data for its ivonescimab lung cancer treatment. The community is heavily focused on the clinical implications of beating the current standard of care and the company's path toward regulatory milestones, despite ongoing debates regarding clinical trial design and short-term volatility.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche (AVAX) is facing significant downward pressure and intense community frustration as it trades near multi-year lows despite institutional milestones like new ETF launches and RWA tokenization partnerships. Investors are actively debating whether these depressed price levels represent a generational buying opportunity or a signal of long-term structural weakness in the altcoin sector.

Zoracles

Zoracles is seeing active community discussion as investors debate its long-term potential against a backdrop of broader crypto market volatility and recent downward pressure. Many users are focusing on accumulation and the importance of patience, highlighting upcoming regulatory catalysts and platform utility as primary drivers for a potential recovery.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is garnering significant attention as a decentralized, AI-native infrastructure project positioned to compete with centralized coding platforms by enabling autonomous agents to manage repositories on-chain. Investors are actively discussing the project's utility-driven tokenomics, aggressive supply reduction strategies, and strategic partnerships, fueling speculation about potential exchange listings and future growth.

Gartner, Inc. is a research and advisory company, which engages in the provision of insights, advice, and tools that help build organizations. It operates through the following segments: Insights, Consulting, Conferences, and Other. The Insights segment equips executives and their teams from every major function, geography, industry and sector with actionable, objective insights, guidance, and tools. The Consulting segment serves the chief information officer and other senior executives who are driving technology-driven strategic initiatives to optimize technology investments and drive business impact. The Conferences segment focuses on information technology and business executives as well as decision makers looking to adapt and evolve their organizations through disruption and uncertainty, navigate risks, and prioritize investments. The company was founded by Gideon I. Gartner and Dave L. R. Stein in 1979 and is headquartered in Stamford, CT.

Gartner, Inc.

Gartner is trending as investors weigh its potential as a long-term enterprise technology bellwether against concerns over slowing contract value growth and potential legal scrutiny regarding its consulting outlook. The community remains divided, with bulls highlighting its essential role in AI adoption cycles, while bears focus on recent price weakness and the competitive threat posed by generative AI to traditional advisory models.

Las Vegas Sands Corp. engages in the development of destination properties. It operates through the Macao and Singapore geographical segments. The Macao segment handles the operations of The Venetian Macao, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Macao, and Sands Macao. The Singapore segment includes the Marina Bay Sands. The company was founded by Sheldon Gary Adelson in August 2004 and is headquartered in Las Vegas, NV.

Las Vegas Sands Corp

Las Vegas Sands is seeing increased attention as the community weighs potential bull flag breakout setups against concerns over the company's reliance on the Macau market and internal leadership dynamics. Investors are actively debating the stock's long-term valuation, with many monitoring the balance between regional growth opportunities and the impact of the company's dividend and buyback programs.

Diamondback Energy, Inc. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and exploitation of unconventional, onshore oil, and natural gas reserves. It operates through the Upstream and Midstream Services segments. The Upstream segment focuses on the Permian Basin operations in West Texas. The Midstream Services segment is involved in the Midland and Delaware Basins. The company was founded in December 2007 and is headquartered in Midland, TX.

Diamondback Energy Inc

Diamondback Energy is currently trending as investors focus on its strong operational efficiency and cost-management strategies within the Permian Basin, even as oil price volatility creates sector-wide uncertainty. Community discussions are heavily centered on the company's production guidance, capital discipline in a fluctuating commodity environment, and its status as a key target for potential industry consolidation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?

Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?

QIAGEN cuts its 2026 growth outlook after a Q1 miss, but margins, cash flow and a debt-free balance sheet could steady the narrative.

QIAGEN Business Breakdown and Growth Drivers for 2026

QGEN targets steadier growth through 2027, leaning on new launches, Connect automation and QIAstat-Dx menu expansion amid choppy demand.

Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific Orbitrap Tribrid Apex and Thermo Scientific Orbitrap Excedion mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific...

Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating?

Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating...

If You Invested $1000 In Thermo Fisher Scientific Stock 20 Years Ago, You Would Have This Much Today

Thermo Fisher Scientific Announces Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo...

Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the companys industry leadership and the essential role of its best-in-class...

Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies

Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies...

Terrestrial Energy Appoints Tyler Gronbach as Vice President of Investor Relations and Public Relations

Terrestrial Energy Inc. (Nasdaq: IMSR) (Terrestrial Energy or the Company), a developer of proprietary Generation IV small modular nuclear power plants, today announced that Tyler Gronbach has joined...

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers’ needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company’s goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company’s history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.

TMO
Thermo Fisher Scientific Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest TMO News

TMOThermo Fisher Scientific Inc.